Medlive Technology Co., Ltd. (02192) disclosed that its issued ordinary shares rose from 738.36 million to approximately 738.93 million as of 4 March 2026. According to the announcement, the increase of roughly 0.57 million shares stemmed from multiple exercises of share options under the company's Pre-IPO Share Option Scheme, each issued at RMB0.38 per share.

On 2 March 2026, 0.24 million shares were issued to employees, while on 4 March 2026, a total of 0.33 million shares were issued to a director and an employee. No treasury shares remain outstanding. The company states that all necessary authorizations and listing requirements have been satisfied, and proceeds relating to the newly issued shares have been duly received.